Biomarker and testing questions
Ask whether the report says HER2-positive, HER2-low, or another HER2 category, and whether retesting matters.
Second-opinion questions
What HER2 result supports this treatment, and are there other HER2-directed options?
Safety discussion reminder
This medicine has important drug-specific warnings. Review the official label and urgent symptom guidance.
Official source links
- NCI cancer drug information (NCI)
- DailyMed label search (DailyMed)
- FDA label search (FDA)
- ClinicalTrials.gov search (ClinicalTrials.gov)